Europe
Clinical News
Informatics
Industry News
Practice Management
Education
Subspecialties
More
Sign In
CT
Digital X-Ray
Interventional
Molecular Imaging
MRI
Radiation Oncology/Therapy
Ultrasound
Womens Imaging
Interventional: Page 161
FDA sets date to review Boston Scientific stent
By
AuntMinnie.com staff writers
The Food and Drug Administration will hold a special panel hearing on November 20 to review Boston Scientific’s premarket approval (PMA) application for the Taxus Express2 paclitaxel-eluting coronary stent.
September 15, 2003
Boston Scientific releases Taxus clinical results
By
AuntMinnie.com staff writers
Interventional device developer Boston Scientific of Natick, MA, presented the nine-month results of its Taxus IV paclitaxel-eluting stent clinical trial at the Transcatheter Cardiovascular Therapeutics symposium in Washington, DC.
September 15, 2003
Groups to collaborate on x-ray visible stent
By
AuntMinnie.com staff writers
Stent developer REVA Medical and the New Jersey Center for Biomaterials, a consortium of Rutgers University, and other groups have teamed up to develop the first resorbable polymer drug-delivery stent that is visible by x-ray.
September 14, 2003
Epix to present phase III results
By
AuntMinnie.com staff writers
MRI contrast developer Epix Medical of Cambridge, MA, is scheduled to present the phase III clinical results of its MS-325 MRI contrast agent being co-developed by the firm and Schering of Berlin at he annual scientific Symposium of Transcatheter Cardiovascular Therapeutics (TCT) in Washington, DC.
September 14, 2003
Boston Scientific’s Taxus stent receives Canadian approval
By
AuntMinnie.com staff writers
Interventional device developer Boston Scientific of Natick, MA, has received approval from Health Canada’s Therapeutic Products Directorate for the sale of its Taxus Express2 paclitaxel-eluting coronary stent system in Canada.
September 11, 2003
TopSpin Medical starts IVMRI trials
By
AuntMinnie.com staff writers
Intravascular MRI developer TopSpin Medical has begun the first human clinical trials of its technology at two sites in Germany, the Universitatskliniken des Saarlandes in Homburg and the Herzzentrum in Siegburg.
September 10, 2003
B. Braun injector system gets 510(k)
By
AuntMinnie.com staff writers
B. Braun Medical has received Food and Drug Administration clearance for its Ultrasite needle-free IV system for interventional radiology applications.
September 10, 2003
Boston Scientific, CryoVascular form alliance
By
AuntMinnie.com staff writers
Boston Scientific and CryoVascular Systems have signed a series of agreements.
September 10, 2003
RITA taps Soto
By
AuntMinnie.com staff writers
Radiofrequency ablation technology provider RITA Medical Systems has appointed John Soto as vice president, international.
September 10, 2003
Neurointerventional procedure to be shown on Web
By
AuntMinnie.com staff writers
An endovascular coil embolization procedure is scheduled for a live Webcast on Tuesday September 16, 2003.
September 9, 2003
Neoprobe gets go-ahead for Quantix/OR
By
AuntMinnie.com staff writers
Neoprobe has received Food and Drug Administration 510(k) clearance for its Quantix/OR intraoperative blood-flow measurement system.
September 8, 2003
Medrad improves assembly-line output
By
AuntMinnie.com staff writers
Vascular injector firm Medrad of Indianola, PA, has installed an automated assembly line that it said has increased the production capacity of its sterile disposables operation by more than 60%.
September 4, 2003
Previous Page
Page 161 of 185
Next Page